The nutraceutical industry has witnessed a notable shift in consumer preferences, and gummies are rapidly gaining popularity as a preferred supplement format. With a global market size valued at US$23.93 billion in 2023 and a projected compound annual growth rate (CAGR) of 11.8% through 2030, gummies offer a convenient and enjoyable alternative to capsules and tablets.¹ However, creating a functional gummy isn’t as simple as making candy with health claims; it demands precision, science-backed, and quality ingredients. That’s where KSM-66 Ashwagandha steps in as the gold standard.

Today’s health-focused consumers want more than just efficacy; they seek experiences. A global survey revealed that 42% prioritize “easy to swallow,” while 21% seek “pleasant taste” in supplements.² Gummies satisfy both preferences, but not every ingredient is suitable for this format.

KSM-66: The ‘go-to’ for gummies

KSM-66 Ashwagandha is the most clinically studied and widely used root-only ashwagandha extract, excelling in gummy applications. Creating effective gummies requires ingredients that have a neutral taste and remain stable at high temperatures, dissolve efficiently, and deliver results at low doses. KSM-66 checks all the boxes:

Exceptional Taste Profile

Taste is crucial for gummies, and KSM-66 Ashwagandha’s neutral taste distinguishes it. Unlike many other extracts or raw ashwagandha powders, KSM-66 is manufactured using a unique, alcohol-free extraction process based on the principles of ‘Green chemistry’ which eliminates the bitterness often associated with the herb. Rigorous sensory evaluations have confirmed its more favorable taste compared to other ashwagandha extracts.

Heat Stability

The production of gummies typically involves a high-temperature cooking process, presenting a significant challenge for several extracts due to their low thermal stability, which leads to the degradation of bioactive components when subjected to heat. KSM-66 Ashwagandha demonstrates exceptional heat stability. Comprehensive research indicates that the extract’s bioactive components stay preserved even at a heating temperature of 100°C.

Solubility and manufacturing efficiency

Solubility is another critical consideration in gummy production. KSM-66 Ashwagandha achieves a perfect balance, offering good water solubility while maintaining free-flowing, non-hygroscopic properties, helping manufacturers ensure stability and consistency in their formulations.

Efficacy at Low Doses

KSM-66 Ashwagandha’s versatility makes it a desirable and effective choice for gummies, with a reduced dosage being a distinct benefit. KSM-66, with a typical dosage of 125–150mg per gummy, offers significant health benefits, as demonstrated in numerous gold-standard clinical studies. A randomized clinical study published in Cureus showed participants taking 125 mg of KSM-66 twice daily had significantly reduced stress and cortisol levels, along with improved sleep quality.³

Quality and safety assured

KSM-66 leads the industry with 46 global certifications, including USDA and EU Organic, Non-GMO Project Verified, Gluten-Free, Halal, Kosher, Certified R.A.W., Certified CLEAN, and many more.

Vegan and Organic

As the wellness market evolves, demand for plant-based, clean-label supplements continues to rise. KSM-66 aligns with this movement through solvent-free extraction and organic cultivation, available in a vegan-certified version.

The Smart Choice for Gummy Innovation

For brand owners, formulators, and manufacturers, KSM-66 offers a complete package: taste, stability, efficacy, safety, quality, and trust. As functional gummies rise in popularity, KSM-66 Ashwagandha stands as the go-to ingredient for products that deliver results consumers can feel and flavors they’ll love.

1. Gummy Market Size, Share & Trends Analysis Report, 2024-2030: https://www.grandviewresearch.com/industry-analysis/gummy-market-report
2. ITC 2023 Insights Supplement Consumer Survey: ://itcinsights.mybigcommerce.com/itc-2023-consumer-supplement-user-report-general/
3. Salve J, Pate S, Debnath K, et al. (December 25, 2019) . Cureus 11(12): e6466. doi:10.7759/cureus.6466

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Any information provided or opinions made in email advertisements are not necessarily those of VRM Media or its owners. Publisher is not liable for advertiser product claims or representations. Advertisers assume total responsibility for the contents of their advertisements.